Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thiol-containing proteins and peptides are defined by the presence of cysteine residues whose side chains bear a thiol (–SH) group[2][6][7]. These thiols are essential for many core biological processes, including antioxidant defense (e.g., glutathione), protein folding via disulfide bond formation, enzymatic catalysis (where cysteine often acts as a reactive nucleophile in active sites), redox signaling, and metal ion coordination[2][3][6]. The structural and functional diversity of thiol-containing proteins allows them to participate in numerous biological pathways, but their identity as a "target" is non-specific: they represent a chemical class, not a single molecular entity. Disruption or modification of protein thiols can contribute to a wide range of diseases—from neurodegeneration to cancer—and many drugs or toxins act by covalently modifying these functional groups[2][3][6][7].
Covalent modification of –SH groups (alkylation, oxidation, metal binding); Redox modulation (altering the oxidative state of thiols); Disulfide bond disruption or formation; Chelation of metal ions
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thiol-containing protein or peptide.